In vitro, we demonstrated the prompt elimination of CAR+ B-leukemia/lymphoma cell lines after exposure of iC9.CAR.CD19-DAUDI and iC9.CAR.CD19-NALM-6 cells to 20 nM of AP1903. Here, CD19 is linked to lymphoma.